Stock Research Archive

Lululemon is a broken growth story, not merely a cheap one. The Q2 FY26 print was the worst in the company's modern history: comparable sales fell 9%, revenue missed consensus, full-year guidance was cut for the second time in 2026, and adjusted operating margin collapsed from 20.7% to 13.2% under t...

Rezolve AI is a high-risk, high-growth agentic commerce play trading at $2.89, down 66% from its 52-week high of $8.45, with a $1.18B market cap. The fundamental story has genuinely inflected: preliminary H1 2026 revenue of ~$127M (nearly 20x YoY), reaffirmed FY2026 guidance of ~$360M, and a string ...

American Airlines is a revenue machine with a balance sheet problem. Q2 2026 delivered record revenue of $16.7B (+16.3% YoY) and beat EPS estimates, yet management cut full-year guidance to a range spanning -$0.65 to +$0.65 per share, citing unhedged fuel exposure from Middle East-driven oil price s...

RedHill Biopharma is a distressed micro-cap biotech trading at $0.90 with a market cap of just $4.02M and only 23 employees. The company has received a Nasdaq non-compliance notification, recently divested its only commercialized product (Talicia) to Apotex for $18M upfront plus milestones, and cont...

CNH Industrial sits at the inflection point of a prolonged agricultural equipment downturn. Q2 2026 results beat expectations ($4.8B revenue, $0.13 adj. EPS vs $0.11 consensus), construction sales grew 12% YoY, and management raised the lower end of full-year guidance as dealer inventories normalize...

Draganfly is a micro-cap drone company trading at $5.42 with a $165.9M market cap against roughly $10-11M in annualized revenue — a P/S ratio north of 15x on a business that is deeply unprofitable. Q2 2026 revenue of $2.66M (+26% YoY) came with a comprehensive loss of $11.8M, more than double the pr...

ServiceNow has staged a dramatic recovery from its 2026 lows near $81-105 to $147.99, driven by Q2 subscription revenue growth of 25% YoY to $3.877B, AI ACV surpassing $1B, and sector-wide relief after Salesforce's blowout quarter validated enterprise AI monetization. The SaaSpocalypse narrative tha...

Aon is a high-quality, capital-light insurance broker with durable mid-single-digit organic growth (5% in Q2 2026), expanding margins (28.9% adjusted, +70bps), and 9% adjusted EPS growth. However, the stock is not obviously cheap: forward P/E of ~20x and EV/EBITDA of ~14x fully reflect modest growth...

enCore Energy is a small-cap US ISR uranium producer trading at $1.25, down 70% from its 52-week high of $4.18. The collapse was not merely commodity-driven: the company faces a securities fraud class action alleging ineffective internal financial controls, improper cost capitalization under GAAP, a...

Lakewood-Amedex is a freshly listed, pre-revenue clinical-stage biotech with a $5.45M market cap, trading 97.5% below its 52-week high of $98.20 just months after its April 2026 direct listing. The collapse reflects the harsh reality facing micro-cap biotechs: no revenue, a Phase 2a asset (Nu-3 for ...

Hut 8 has executed a genuine transformation from a bitcoin miner into an AI data center landlord. The contracted portfolio now stands at 949 MW of IT capacity, ~$26.6B in aggregate base-term contract value, and >$1.75B of expected average annual NOI from investment-grade tenants (including a $9.8B 1...

SELLAS Life Sciences is a $2.67B market-cap clinical-stage biotech with $138.3M in cash, no revenue, and 13 employees, trading 859% above its 52-week low and just 16% below its high. The entire investment case hinges on the imminent final analysis of the Phase 3 REGAL trial of galinpepimut-S in AML ...

Duolingo has rebounded sharply from the March bottom ($95.35) to $148.36, up ~56% and already above my prior 1Y target of $125. The Q2 2026 print validated the core of my prior thesis: DAU growth accelerated to 23% YoY (58.7M DAUs), retention hit an all-time high, and the company is executing its de...

Howmet Aerospace is executing exceptionally well: Q2 2026 revenue grew 24% (21% organic), adjusted EPS grew 46%, EBITDA grew 39% with margin expansion, and full-year guidance was raised 11% after beating the high end of guidance. The company holds >50% global share in IGT turbine blades, giving it a...

Viking Holdings is a genuinely differentiated business: dominant in river cruising for North American outbound passengers, 95% occupancy, 16-17% revenue growth, and net leverage of just 1.2x — exceptional for a capital-intensive cruise operator. Q2 2026 results (revenue $2.19B, +16.5%; Adjusted EBIT...

Sono Group is no longer a solar mobility company — it has abandoned its legacy Sion/solar business entirely and morphed into a micro-cap Bitcoin treasury vehicle with a speculative LOI to enter professional sports franchise ownership. The financial picture is dire: after a ~$5 million Bitcoin bet, t...

Qualcomm sits at a genuine inflection point: the legacy handset business is contracting (Q2 CY2026 revenue down 4% YoY, handset revenue $5.1B pressured by memory cost inflation and Apple attrition), while the diversification story — automotive at a record $1.6B (+61% YoY), IoT up 9%, and a newly qua...

Take-Two enters the most consequential 12 months in its history with Grand Theft Auto VI launching November 19, 2026 — widely projected to be the largest entertainment release ever, with analyst estimates of 40-45+ million units in year one. FY2027 guidance of $8-8.2B in net bookings implies ~30%+ g...

Strive (ASST) is a leveraged bitcoin treasury vehicle wrapped in an asset-management story, and the market is currently paying a large premium for it. At $24.22 with a ~$1.95B market cap, the stock trades at roughly 1.69x mNAV per the most recent independent analysis — versus MicroStrategy at ~1.00x...

Standard Nuclear is a freshly IPO'd, pre-scale TRISO nuclear fuel manufacturer trading at $16.11, up ~128% from its 52-week low but only ~4% below its high. The fundamental story is genuinely improving: Q2 2026 revenue rose roughly eightfold, total contract backlog grew six-fold since March to $576....